Skip to main content
Caplight Logo









Dalriada Drug Discovery

Dalriada Drug Discovery

Private
Mississauga, OntarioHealthcare & Life Scienceshttps://dalriadatx.com/

Last Round

Grant

Feb 20, 2018

Total Funding Raised

$179,000

Company Overview

Dalriada Drug Discovery is a contract research organization that provides small molecule drug discovery services for the biotechnology and pharmaceutical industries.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

contract research organizationCROdrug discoverymedicinal chemistrysmall molecule therapeuticscomputational chemistryCADDpharmacokineticsPKADMEchemoproteomicsassay developmentoutsourced R&Dbiotech servicesdrug discovery lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dalriada Drug Discovery Comparables

Compare Dalriada Drug Discovery with similar companies based on industry and business-model similarity.

Dalriada Drug Discovery comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Domainex Ltd
85%
Concept Life Sciences
80%
Sygnature Discovery
79%

Dalriada Drug Discovery Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 20, 2018
GrantApr 5, 2017

Key People

Founding team and executive leadership

Kelly De Freitas

Chief Financial Officer

Executive Team

Dalriada Drug Discovery Investors

Notable investors and investment history

Dalriada Drug Discovery investors
InvestorRounds
Royal Bank Of CanadaGrant
TIAPGrant
FACITGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 30, 2026

    Monthly visitors grew 243% MoM, from 516 to 1.8K.

  • May 2, 2025

    Monthly visitors grew 108% MoM, reaching 961.

Dalriada Drug Discovery Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Dalriada Drug Discovery Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Dalriada Drug Discovery's valuation, stock price, and market status.

Firmographic Details

HeadquartersMississauga, Ontario
Employee Range39
Year Founded2017
Last FundingFeb 20, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?